A progress toward research on alternative splicing of genes in tumor cells.
- Author:
Zhu-ren ZHOU
1
;
Kai-lai SUN
Author Information
1. Department of Medical Genetics, China Medical University, Shenyang, Liaoning, 110001 P.R.China.
- Publication Type:Journal Article
- MeSH:
Alternative Splicing;
genetics;
Humans;
Neoplasms;
genetics;
RNA Precursors;
metabolism;
RNA, Neoplasm;
analysis;
Transcription, Genetic
- From:
Chinese Journal of Medical Genetics
2006;23(2):177-180
- CountryChina
- Language:Chinese
-
Abstract:
Alternative splicing of pre-mRNA is an important mechanism for regulating gene function at the post-transcription level and for producing proteomic diversity in higher eukaryotes. The alternative splicing is regulated by the interaction between diverse cis-acting elements and trans-acting factors. Alternative splicing events of oncogenes, tumor suppressor genes and metastasis suppressor genes are associated with the initiation and development of human neoplasms. The protein isoforms sourced from alternative splicing take part in regulating the gene transcription, cell cycle, apoptosis of cells, and playing a role in tumor growth. It is possible for molecular therapy to target directly isoforms of protein produced by alternative splicing or to interfere with the process of alternative splicing.
